Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 11, Issue 2, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-12
DOI
10.1038/s41419-020-2229-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression
- (2017) Teresa Ramirez et al. JOURNAL OF HEPATOLOGY
- Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis
- (2017) Xue-Ke Zhao et al. Scientific Reports
- Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology
- (2016) Raghuveera Kumar Goel et al. CANCER AND METASTASIS REVIEWS
- TGF-β signalling and liver disease
- (2016) Isabel Fabregat et al. FEBS Journal
- Fyn deficiency attenuates renal fibrosis by inhibition of phospho-STAT3
- (2016) Hye-Young Seo et al. KIDNEY INTERNATIONAL
- Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis
- (2016) Yanli Yan et al. KIDNEY INTERNATIONAL
- Hepatic fibrosis: Concept to treatment
- (2015) Christian Trautwein et al. JOURNAL OF HEPATOLOGY
- S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase
- (2015) Pulin Che et al. Scientific Reports
- N-WASP-directed actin polymerization activates Cas phosphorylation and lamellipodium spreading
- (2014) X. Zhang et al. JOURNAL OF CELL SCIENCE
- Neuronal Wiskott-Aldrich syndrome protein (N-WASP) is critical for formation of α-smooth muscle actin filaments during myofibroblast differentiation
- (2012) Guo-Qiang Cai et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Fibrosis-dependent mechanisms of hepatocarcinogenesis
- (2012) David Y. Zhang et al. HEPATOLOGY
- Mechanisms of hepatic fibrogenesis
- (2011) Ursula E. Lee et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Fyn mediates transforming growth factor-beta1-induced down-regulation of E-cadherin in human A549 lung cancer cells
- (2011) An Na Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TGF-β1 Induces Podocyte Injury Through Smad3-ERK-NF-κB Pathway and Fyn-dependent TRPC6 phosphorylation
- (2011) Lixia Yu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice
- (2011) Won-Il Jeong et al. HEPATOLOGY
- A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study
- (2009) Primo N. Lara et al. ANTI-CANCER DRUGS
- Actin filament nucleation and elongation factors – structure–function relationships
- (2009) Roberto Dominguez CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
- (2009) Tim P. Green et al. Molecular Oncology
- Src kinases in systemic sclerosis: Central roles in fibroblast activation and in skin fibrosis
- (2008) Catherine Skhirtladze et al. ARTHRITIS AND RHEUMATISM
- Focal Adhesion Kinase (FAK)-related Non-kinase Inhibits Myofibroblast Differentiation through Differential MAPK Activation in a FAK-dependent Manner
- (2008) Qiang Ding et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530
- (2008) Y-M Chang et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started